We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPAI:NASDAQSafe Pro Group Inc. Analysis

Data as of 2026-05-26 - not real-time

$4.23

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Safe Pro Group Inc. (SPAI) is trading at $4.23, just below its 20‑day ($4.30) and 50‑day ($4.28) simple moving averages, indicating short‑term weakness. The RSI sits at 49 and the MACD histogram is negative, reinforcing a neutral‑to‑bearish technical outlook. Fundamentally, the company reports negative operating margins (-2.39%), zero net profit, and a sizable cash burn (operating cash flow of -$6.45M), while its price‑to‑sales ratio of 53x and price‑to‑book of 5.6x suggest the stock is priced well above its earnings and book value.
Recent material news highlights the launch of a government growth team and a master teaming agreement to deliver AI‑enabled battlefield intelligence, which could unlock new contract revenue streams. However, the company’s high beta (2.3) and 30‑day volatility of over 70% expose investors to significant price swings. With a market cap under $90M and a max drawdown of nearly 64%, the upside potential cited by analysts (152% upside) comes with substantial downside risk. The consensus recommendation is a "strong buy," but the underlying financials and risk profile warrant a cautious, nuanced approach.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD signal
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • New government growth team and AI contract pipeline
  • Improving earnings surprise (+6.7%)
  • Continued cash burn limiting upside

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential upside to $10+ target price
  • Strategic positioning in AI‑driven defense solutions
  • Elevated risk from negative cash flows and high beta

Key Metrics & Analysis

Financial Health

Revenue Growth560.20%
ROE-145.63%
ROA-77.28%
Debt/Equity4.02
P/B Ratio5.6
Op. Cash Flow$-6452592
Free Cash Flow$-2161478
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI49.0
Support$3.81
Resistance$4.81
MA 20$4.30
MA 50$4.28
MA 200$5.18
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Target Price$10.67
Upside/Downside152.17%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.31
Volatility73.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.